Combining docking site and phosphosite predictions to find new substrates: identification of smoothelin-like-2 (SMTNL2) as a c-Jun N-terminal kinase (JNK) substrate.

[1]  J. Forwood,et al.  Altered mitogen‐activated protein kinase signaling in dystrophic (mdx) muscle , 2012, Muscle & nerve.

[2]  F. Pontén,et al.  Antibodies for profiling the human proteome—The Human Protein Atlas as a resource for cancer research , 2012, Proteomics.

[3]  Alejo E. Rodriguez-Fraticelli,et al.  Synaptotagmin-Like Proteins Control Formation of a Single Apical Membrane Domain in Epithelial Cells , 2012, Nature Cell Biology.

[4]  Bin Zhang,et al.  PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse , 2011, Nucleic Acids Res..

[5]  T. Borsello,et al.  The JNK signalling transduction pathway in the brain. , 2012, Frontiers in bioscience.

[6]  F. Pontén,et al.  The Human Protein Atlas as a proteomic resource for biomarker discovery , 2011, Journal of internal medicine.

[7]  Enxuan Jing,et al.  Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production , 2011, Proceedings of the National Academy of Sciences.

[8]  T. Jacks,et al.  Requirement of c-Jun NH2-Terminal Kinase for Ras-Initiated Tumor Formation , 2011, Molecular and Cellular Biology.

[9]  Dennis B. Troup,et al.  NCBI GEO: archive for functional genomics data sets—10 years on , 2010, Nucleic Acids Res..

[10]  G. Sabio,et al.  cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance. , 2010, Trends in biochemical sciences.

[11]  Pierre Baldi,et al.  Computational Prediction and Experimental Verification of New MAP Kinase Docking Sites and Substrates Including Gli Transcription Factors , 2010, PLoS Comput. Biol..

[12]  Claude Bouchard,et al.  Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. , 2010, Journal of applied physiology.

[13]  Natasa Przulj,et al.  Characterization of cell cycle specific protein interaction networks of the yeast 26S proteasome complex by the QTAX strategy. , 2010, Journal of proteome research.

[14]  A. Levchenko,et al.  Visualization of JNK activity dynamics with a genetically encoded fluorescent biosensor , 2010, Proceedings of the National Academy of Sciences.

[15]  M. Bogoyevitch,et al.  c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges. , 2010, Biochimica et biophysica acta.

[16]  Jason K. Kim,et al.  Role of Muscle c-Jun NH2-Terminal Kinase 1 in Obesity-Induced Insulin Resistance , 2009, Molecular and Cellular Biology.

[17]  Lee Bardwell,et al.  Selectivity of Docking Sites in MAPK Kinases* , 2009, Journal of Biological Chemistry.

[18]  Joseph Avruch,et al.  MAP kinase pathways: the first twenty years. , 2007, Biochimica et biophysica acta.

[19]  Kazuhiro Nakamura,et al.  The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. , 2007, Biochimica et biophysica acta.

[20]  Bostjan Kobe,et al.  Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases , 2006, Microbiology and Molecular Biology Reviews.

[21]  W. Lim,et al.  Docking interactions in protein kinase and phosphatase networks. , 2006, Current opinion in structural biology.

[22]  Lee Bardwell,et al.  Analysis of mitogen-activated protein kinase activation and interactions with regulators and substrates. , 2006, Methods.

[23]  L. Bardwell,et al.  Mechanisms of MAPK signalling specificity. , 2006, Biochemical Society transactions.

[24]  P. Thompson,et al.  Analysis of human skeletal muscle after 48 h immobilization reveals alterations in mRNA and protein for extracellular matrix components. , 2006, Journal of applied physiology.

[25]  Michael Beckstette,et al.  Fast index based algorithms and software for matching position specific scoring matrices , 2006, BMC Bioinformatics.

[26]  Lee Bardwell,et al.  Interacting JNK-docking Sites in MKK7 Promote Binding and Activation of JNK Mitogen-activated Protein Kinases* , 2006, Journal of Biological Chemistry.

[27]  J. D. Porter,et al.  Distinctive morphological and gene/protein expression signatures during myogenesis in novel cell lines from extraocular and hindlimb muscle. , 2006, Physiological genomics.

[28]  L. Bardwell,et al.  Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo. , 2006, Cellular signalling.

[29]  A. Nakamura,et al.  Up-regulation of mitogen activated protein kinases in mdx skeletal muscle following chronic treadmill exercise. , 2005, Biochimica et biophysica acta.

[30]  J. Zierath,et al.  Effects of insulin, contraction, and phorbol esters on mitogen-activated protein kinase signaling in skeletal muscle from lean and ob/ob mice. , 2004, Diabetes.

[31]  A. Vercelli,et al.  A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia , 2003, Nature Medicine.

[32]  Lee Bardwell,et al.  A Docking Site in MKK4 Mediates High Affinity Binding to JNK MAPKs and Competes with Similar Docking Sites in JNK Substrates* , 2003, Journal of Biological Chemistry.

[33]  Mei Han,et al.  Gene expression profiling of Duchenne muscular dystrophy skeletal muscle , 2003, Neurogenetics.

[34]  Lee Bardwell,et al.  Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity. , 2003, The Biochemical journal.

[35]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[36]  M. Bogoyevitch,et al.  Identification of the Critical Features of a Small Peptide Inhibitor of JNK Activity* , 2002, The Journal of Biological Chemistry.

[37]  R. Davis,et al.  Regulation of MAP kinases by docking domains , 2001, Biology of the cell.

[38]  M. Rudnicki,et al.  Activation of JNK1 contributes to dystrophic muscle pathogenesis , 2001, Current Biology.

[39]  L. Flatauer,et al.  A Conserved Docking Site in MEKs Mediates High-affinity Binding to MAP Kinases and Cooperates with a Scaffold Protein to Enhance Signal Transmission* , 2001, The Journal of Biological Chemistry.

[40]  J. Veerkamp,et al.  Differentiation markers of mouse C2C12 and rat L6 myogenic cell lines and the effect of the differentiation medium , 1999, In Vitro Cellular & Developmental Biology - Animal.

[41]  N. Tonks,et al.  Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. , 1997, Science.